drugset / Trial / NCT03164512
The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol
RandomizedCrossoverDouble-blindBasic science
Summary
This study will evaluate the pharmacokinetics and pharmacodynamics of cannabidiol administered via inhalation and oral ingestion.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2019-08-29
- Completion
- 2020-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 100 mg | Inhaled |
Indications
No indication recorded.